Top

Published in:

01-08-2019 | Migraine | Brief Communication

Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine

Authors: Piero Barbanti, Fiorella Guadagni, Maria Laura De Marchis, Cristiano Ialongo, Gabriella Egeo, Luisa Fofi, Cinzia Aurilia, Domenica Lovero, David Della-Morte, Patrizia Ferroni, Raffaele Palmirotta

Published in: Neurological Sciences | Issue 8/2019

Abstract

Dopamine-beta-hydroxylase (DBH) enzyme activity is modulated at the genetic level by the presence of several polymorphisms. Among these, the 19-bp insertion/deletion (I/D) polymorphism (rs72393728/rs141116007) was investigated in several genetic association studies for its correlation with the susceptibility to develop episodic migraine, but conflicting results were achieved. In the present study we analyzed this genetic variant in a carefully characterized population of migraineurs encompassing both episodic and chronic migraine (with and without medication overuse) with the aim to perform a replication study and verify any possible correlation with migraine endophenotypes. Genotyping of the DBH 19-bp I/D polymorphism was performed on 400 migraine patients and 204 healthy individuals. The associations between genotypic frequencies and the clinical and sociodemographic features of migraineurs were then investigated. The DBH 19-bp I/D polymorphism did not correlate with migraine susceptibility or most clinical variables, with the exception of a statistically significant correlation within the subgroup of patients affected by chronic migraine were the individuals carrying the deleted (D) allele were significantly more prone to abuse in analgesics. As a result of this finding, the DBH 19-bp I/D polymorphism does not influence migraine susceptibility, but it might contribute to the development of medication overuse in patient with chronic migraine.

Barbanti P, Fofi L, Aurilia C, Egeo G (2013) Dopaminergic symptoms in migraine. Neurol Sci 34(Suppl 1):S67–S70. https://doi.org/10.1007/s10072-013-1415-8 CrossRefPubMed

Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49(1):201–206CrossRef

Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, Piccardi MP (1998) Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 51(3):781–786CrossRef

Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3(1):35–40PubMed

Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23(6):301–305. https://doi.org/10.1007/s100720300005 CrossRefPubMed

Fernandez F, Lea RA, Colson NJ, Bellis C, Quinlan S, Griffiths LR (2006) Association between a 19 bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 251(1–2):118–123. https://doi.org/10.1016/j.jns.2006.09.013 CrossRefPubMed

Cevoli S, Mochi M, Scapoli C, Marzocchi N, Pierangeli G, Pini LA, Cortelli P, Montagna P (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13(9):1009–1013. https://doi.org/10.1111/j.1468-1331.2006.01415.x CrossRefPubMed

Todt U, Netzer C, Toliat M, Heinze A, Goebel I, Nurnberg P, Gobel H, Freudenberg J, Kubisch C (2009) New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 125(3):265–279. https://doi.org/10.1007/s00439-009-0623-z CrossRefPubMed

Ghosh J, Pradhan S, Mittal B (2011) Role of dopaminergic gene polymorphisms (DBH 19 bp indel and DRD2 Nco I) in genetic susceptibility to migraine in North Indian population. Pain Med 12(7):1109–1111. https://doi.org/10.1111/j.1526-4637.2011.01153.x CrossRefPubMed

10.

Ghosh J, Pradhan S, Mittal B (2013) Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility. NeuroMolecular Med 15(1):61–73. https://doi.org/10.1007/s12017-012-8195-9 CrossRefPubMed

11.

De Marchis ML, Barbanti P, Palmirotta R, Egeo G, Aurilia C, Fofi L, Piroso S, Ialongo C, Della-Morte D, D'Andrea G, Ferroni P, Guadagni F (2015) Look beyond catechol-O-methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study. J Headache Pain 16:520. https://doi.org/10.1186/s10194-015-0520-x CrossRefPubMed

12.

Kemper CM, O'Connor DT, Westlund KN (1987) Immunocytochemical localization of dopamine-beta-hydroxylase in neurons of the human brain stem. Neuroscience 23(3):981–989CrossRef

13.

Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44(1):53–64. https://doi.org/10.1111/j.1526-4610.2004.04011.x CrossRefPubMed

14.

Weinshilboum RM, Raymond FA, Elveback LR, Weidman WH (1973) Serum dopamine-beta-hydroxylase activity: sibling-sibling correlation. Science 181(4103):943–945CrossRef

15.

Cubells JF, Zabetian CP (2004) Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology. Psychopharmacology 174(4):463–476. https://doi.org/10.1007/s00213-004-1840-8 CrossRefPubMed

16.

Tang YL, Epstein MP, Anderson GM, Zabetian CP, Cubells JF (2007) Genotypic and haplotypic associations of the DBH gene with plasma dopamine beta-hydroxylase activity in African Americans. Eur J Hum Genet 15(8):878–883. https://doi.org/10.1038/sj.ejhg.5201838 CrossRefPubMed

17.

Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW (1988) Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48(1):48–50CrossRef

18.

Fernandez F, Colson N, Quinlan S, MacMillan J, Lea RA, Griffiths LR (2009) Association between migraine and a functional polymorphism at the dopamine beta-hydroxylase locus. Neurogenetics 10(3):199–208. https://doi.org/10.1007/s10048-009-0176-2 CrossRefPubMed

19.

Corominas R, Ribases M, Camina M, Cuenca-Leon E, Pardo J, Boronat S, Sobrido MJ, Cormand B, Macaya A (2009) Two-stage case-control association study of dopamine-related genes and migraine. BMC Med Genet 10:95. https://doi.org/10.1186/1471-2350-10-95 CrossRefPubMedPubMedCentral

20.

Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J (2000) A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5(1):56–63CrossRef

21.

Chen H, Ji CX, Zhao LL, Kong XJ, Zeng XT (2015) Association between polymorphisms of DRD2, COMT, DBH, and MAO-A genes and migraine susceptibility: a meta-analysis. Medicine 94(47):e2012. https://doi.org/10.1097/MD.0000000000002012 CrossRefPubMedPubMedCentral

22.

Gormley P, Anttila V, Winsvold BS, Palta P, Esko T, Pers TH, Farh KH, Cuenca-Leon E, Muona M, Furlotte NA, Kurth T, Ingason A, McMahon G, Ligthart L, Terwindt GM, Kallela M, Freilinger TM, Ran C, Gordon SG, Stam AH, Steinberg S, Borck G, Koiranen M, Quaye L, Adams HH, Lehtimaki T, Sarin AP, Wedenoja J, Hinds DA, Buring JE, Schurks M, Ridker PM, Hrafnsdottir MG, Stefansson H, Ring SM, Hottenga JJ, Penninx BW, Farkkila M, Artto V, Kaunisto M, Vepsalainen S, Malik R, Heath AC, Madden PA, Martin NG, Montgomery GW, Kurki MI, Kals M, Magi R, Parn K, Hamalainen E, Huang H, Byrnes AE, Franke L, Huang J, Stergiakouli E, Lee PH, Sandor C, Webber C, Cader Z, Muller-Myhsok B, Schreiber S, Meitinger T, Eriksson JG, Salomaa V, Heikkila K, Loehrer E, Uitterlinden AG, Hofman A, van Duijn CM, Cherkas L, Pedersen LM, Stubhaug A, Nielsen CS, Mannikko M, Mihailov E, Milani L, Gobel H, Esserlind AL, Christensen AF, Hansen TF, Werge T, International Headache Genetics C, Kaprio J, Aromaa AJ, Raitakari O, Ikram MA, Spector T, Jarvelin MR, Metspalu A, Kubisch C, Strachan DP, Ferrari MD, Belin AC, Dichgans M, Wessman M, van den Maagdenberg AM, Zwart JA, Boomsma DI, Smith GD, Stefansson K, Eriksson N, Daly MJ, Neale BM, Olesen J, Chasman DI, Nyholt DR, Palotie A (2016) Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 48(8):856–866. https://doi.org/10.1038/ng.3598

23.

Nahmias J, Burley MW, Povey S, Porter C, Craig I, Wolfe J (1992) A 19 bp deletion polymorphism adjacent to a dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase locus. Hum Mol Genet 1(4):286CrossRef

24.

Palmirotta R, Barbanti P, Ludovici G, Egeo G, Aurilia C, Fofi L, De Marchis ML, Spila A, Ferroni P, Della-Morte D, Guadagni F (2013) Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM). Neurol Sci 34(9):1659–1663. https://doi.org/10.1007/s10072-013-1308-x CrossRefPubMed

25.

Studies N-NWGoRiA, Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P, Fraumeni JF Jr, Freimer NB, Gerhard DS, Gunter C, Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R, Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ, Wacholder S, Wijsman EM, Winn DM, Collins FS (2007) Replicating genotype-phenotype associations. Nature 447(7145):655–660. https://doi.org/10.1038/447655a CrossRef

26.

Olesen J (2016) Migraine: are migraine endophenotypes needed? Nat Rev Neurol 12(6):320–321. https://doi.org/10.1038/nrneurol.2016.31 CrossRefPubMed

27.

Barbanti P, Aurilia C, Dall'Armi V, Egeo G, Fofi L, Bonassi S (2016) The phenotype of migraine with unilateral cranial autonomic symptoms documents increased peripheral and central trigeminal sensitization. A case series of 757 patients. Cephalalgia 36(14):1334–1340. https://doi.org/10.1177/0333102416630579 CrossRefPubMed

28.

The International Classification of Headache Disorders, 3rd edition (beta version) (2013) Cephalalgia 33(9):629–808. https://doi.org/10.1177/0333102413485658 CrossRef

29.

Covelli V, Guastafierro E, Raggi A, Grazzi L, Leonardi M, Scaratti C, Bartolini M, Viticchi G, Cevoli S, Pierangeli G, Tedeschi G, Russo A, Barbanti P, Aurilia C, Lovati C, Giani L, Fredian F, Di Fiore P, Bono F, Rapisarda L, D’Amico D (2018) The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire. Neurol Sci 39(Suppl 1):131–133. https://doi.org/10.1007/s10072-018-3363-9 CrossRefPubMed

30.

Palmirotta R, Ludovici G, De Marchis ML, Savonarola A, Leone B, Spila A, De Angelis F, Della Morte D, Ferroni P, Guadagni F (2011) Preanalytical procedures for DNA studies: the experience of the Interinstitutional Multidisciplinary BioBank (BioBIM). Biopreserv Biobanking 9(1):35–45. https://doi.org/10.1089/bio.2010.0027 CrossRef

31.

Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76(5):887–893. https://doi.org/10.1086/429864 CrossRefPubMedPubMedCentral

32.

Ialongo C (2016) Understanding the effect size and its measures. Biochemia Medica 26(2):150–163. https://doi.org/10.11613/BM.2016.015 CrossRefPubMedPubMedCentral

33.

Chasman DI, Anttila V, Buring JE, Ridker PM, Schurks M, Kurth T, International Headache Genetics C (2014) Selectivity in genetic association with sub-classified migraine in women. PLoS Genet 10(5):e1004366. https://doi.org/10.1371/journal.pgen.1004366 CrossRefPubMedPubMedCentral

34.

Barbanti P, Fofi L, Cevoli S, Torelli P, Aurilia C, Egeo G, Grazzi L, D'Amico D, Manzoni GC, Cortelli P, Infarinato F, Vanacore N (2018) Establishment of an Italian chronic migraine database: a multicenter pilot study. Neurol Sci 39(5):933–937. https://doi.org/10.1007/s10072-018-3280-y CrossRefPubMed

35.

Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P (2009) Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49(3):412–418. https://doi.org/10.1111/j.1526-4610.2008.01257.x CrossRefPubMed

36.

Cargnin S, Viana M, Sances G, Bianchi M, Ghiotto N, Tassorelli C, Nappi G, Canonico PL, Genazzani AA, Terrazzino S (2014) Combined effect of common gene variants on response to drug withdrawal therapy in medication overuse headache. Eur J Clin Pharmacol 70(10):1195–1202. https://doi.org/10.1007/s00228-014-1726-6 CrossRefPubMed

37.

D'Andrea G, D'Amico D, Bussone G, Bolner A, Aguggia M, Saracco MG, Galloni E, De Riva V, Colavito D, Leon A, Rosteghin V, Perini F (2013) The role of tyrosine metabolism in the pathogenesis of chronic migraine. Cephalalgia 33(11):932–937. https://doi.org/10.1177/0333102413480755 CrossRefPubMed

38.

Ferraro S, Grazzi L, Muffatti R, Nava S, Ghielmetti F, Bertolino N, Mandelli ML, Visintin E, Bruzzone MG, Nigri A, Epifani F, Bussone G, Chiapparini L (2012) In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas. Headache 52(10):1520–1534. https://doi.org/10.1111/j.1526-4610.2012.02276.x CrossRefPubMed

39.

Fumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129(Pt 2):543–550. https://doi.org/10.1093/brain/awh691 CrossRefPubMed

40.

Dunnett SB, Robbins TW (1992) The functional role of mesotelencephalic dopamine systems. Biol Rev Camb Philos Soc 67(4):491–518CrossRef

41.

Zeeb FD, Floresco SB, Winstanley CA (2010) Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues. Psychopharmacology 211(1):87–98. https://doi.org/10.1007/s00213-010-1871-2 CrossRefPubMed

42.

Cortese F, Pierelli F, Pauri F, Di Lorenzo C, Lepre C, Malavolta G, Merluzzo C, Parisi V, Serrao M, Coppola G (2019) Short-term cortical synaptic depression/potentiation mechanisms in chronic migraine patients with or without medication overuse. Cephalalgia 39(2):237–244. https://doi.org/10.1177/0333102418784747 CrossRefPubMed

Title: Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine
Authors: Piero Barbanti
Fiorella Guadagni
Maria Laura De Marchis
Cristiano Ialongo
Gabriella Egeo
Luisa Fofi
Cinzia Aurilia
Domenica Lovero
David Della-Morte
Patrizia Ferroni
Raffaele Palmirotta
Publication date: 01-08-2019
Publisher: Springer International Publishing
Keywords: Migraine
Aura
Published in: Neurological Sciences / Issue 8/2019
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-03865-9

ACC 2024 Congress

Springer Medicine

Dopamine-beta-hydroxylase 19-bp insertion/deletion polymorphism affects medication overuse in patients with chronic migraine

Abstract

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2019

Choosing Wisely: five recommendations related to tests, treatments, and procedures at risk of inappropriateness in the cure of Parkinson’s disease (LIMPE-DISMOV Academy)

Propofol alleviates cisplatin-related cognitive impairment

Dystonin/BPAG1 modulates diabetes and Alzheimer’s disease cross-talk: a meta-analysis

Causes of chronic neuropathies: a single-center experience

A complex relation between depression and multiple sclerosis: a descriptive review

Endovascular therapy for acute ischemic stroke: which role for neurologists?